Recordati | REC - Ebit

Stock Price
54.15
Daily Change
0.10 0.19%
Monthly
7.02%
Yearly
4.44%
Q3 Forecast
53.61

Recordati reported EUR143.93M in EBIT for its fiscal quarter ending in June of 2025.



Financials
Stock Price EUR
Assets EUR 5.18B
Cash and Equivalent EUR 341.55M
Cost of Sales EUR 220.03M
Current Assets EUR 1.57B
Current Liabilities EUR 1.07B
Debt EUR 2.47B
Dividend Yield 2.38
EBIT EUR 143.93M
EBITDA EUR 226.19M
Employees 4.37K
EPS Earnings Per Share EUR 0.74
Equity Capital and Reserves EUR 1.87B
Gross Profit on Sales EUR 423.85M
Interest Expense on Debt EUR 24.49M
Loan Capital EUR 2.09B
Market Capitalization EUR 11.13B
Net Income EUR 91.08M
Operating Expenses EUR 493.93M
Operating Profit EUR 149.95M
Ordinary Share Capital EUR 205.56M
PE Price to Earnings EUR 26.71
Pre-Tax Profit EUR 119.49M
Sales Revenues EUR 643.15M
Selling and Administration Expenses EUR 186.98M
Stock EUR 493.63M
Trade Creditors EUR 330.22M
Trade Debtors EUR 700.23M

Ebit Change Date
Almirall EUR 43.02M 3.42M Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Orion EUR 104.6M 26.7M Jun/2025
Sanofi EUR 1.51B 1.39B Jun/2025